Summit Biosciences Announces Successful FDA Preapproval Inspection for Manufacturing of Nasal Spray Drug Product
Summit Biosciences Inc., a specialty pharmaceutical company, is pleased to announce that the manufacturing facility in Lexington, Kentucky has successfully passed its first preapproval inspection by the Food and Drug Administration (FDA). The inspection for a new nasal spray drug product, which... - March 28, 2014
Press Releases 1 - 1 of 1